Who Paid My Doc
A Phase 3 Study of Pembrolizumab in Combination with Pemetrexed,Platinum Carboplatin or Cisplatin Followed by Pembrolizumab and Maintenance Olaparib vs Maintenance Pemetrexed in the First-Line Treatment of Participants with Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Research payments
$4,441,644
Through program year 2023, $4,441,644 in research payments was reported against A Phase 3 Study of Pembrolizumab in Combination with Pemetrexed,Platinum Carboplatin or Cisplatin Followed by Pembrolizumab and Maintenance Olaparib vs Maintenance Pemetrexed in the First-Line Treatment of Participants with Metastatic Nonsquamous Non-Small-Cell Lung Cancer, across 292 payments, paid by Merck Sharp & Dohme Corporation.
- Paid by
- Merck Sharp & Dohme Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $130,616 | 3 |
| 2022 | Research | $210,723 | 6 |
| 2021 | Research | $3,133,385 | 40 |
| 2020 | Research | $733,965 | 190 |
| 2019 | Research | $232,955 | 53 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Santosh Nair Orange City, FL Named on 78 payments
- Hirva Mamdani Detroit, MI Named on 65 payments
- Andrew Pippas Columbus, GA Named on 27 payments
- Mary Crow Kingwood, TX Named on 25 payments
- Jhanelle Gray Tampa, FL Named on 21 payments
- Manuel Rosado Rolling Meadows, IL Named on 20 payments
- John Hrom Hattiesburg, MS Named on 12 payments
- Mohammed Kassem Chicago, IL Named on 8 payments
- Justin Thomas Bozeman, MT Named on 5 payments
- Mahsa Mohebtash Baltimore, MD Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.